ProBiotix Health adds CholBiomeVH formula to cardiovascular probiotics line

ProBiotix Health Plc (UK) is now offering a private-label probiotic formula called CholBiome_VH. Targeting the heart health market, CholBiome_VH leverages ProBiotix Health’s experience in probiotics. The formula joints three other existing formulas in the CholBiome cardiovascular probiotic line: CholBiome, CholBiome_x3, and CholBiome_BP.

All of these formulas feature the ProBiotix LP_LDL Lactobacillus plantarum probiotic ingredient. This patented probiotic strain has been shown to improve key cardiovascular biomarkers, including cholesterol (reducing LDL and increasing HDL) and blood pressure.

The company describes CholBiome_VH as “a vascular health formula that combines three specialized ingredients in a triple-layer tablet.” It comprises LP_LDL, thiamine, and Vitamin K2 Vital (from Kappa Bioscience) “to provide a multi-targeted mechanism to work against the buildup of lipid and calcium deposits in blood vessels.”